Readycell develops, implements and commercialize new innovative kits through strategic partnership with other emerging market players: Biotechnological, Pharmaceutical & Med Dev companies and Research Centers.

  • R&D support projects with high predictable and/or regulatory value.
  • Acceleration and optimization of decision-making process.
  • Evaluation of active molecules: Action, mechanisms, ADME, Efficacy, Toxicity, Screening and optimization, Active concept proof and NCEs (New Chemical Entities).
  • In silico modeling and Bioinformatic analysis.
  • High throughput in vivo studies in Zebrafish
  • Custom projects.